Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Wnt and lithium: a common destiny in the therapy of nervous system pathologies?
Validation and cross-cultural adaptation of sexual dysfunction modified scale in multiple sclerosis for Brazilian population.
Change in perceived health insurance coverage among people with multiple sclerosis.
Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics.
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker.
Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
Neuroimmune semaphorin 4A as a drug and drug target for asthma.
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
[Symptoms and clinical manifestations in neuromyelitis optica].
Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.
Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.
BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in Multiple Sclerosis patients.
Osmotic Demyelination Syndrome as the Initial Manifestation of a Hyperosmolar Hyperglycemic State.
Regulation of human glia by multiple sclerosis disease modifying therapies.
Long-term effects of whole body cryostimulation on uric acid concentration in plasma of secondary progressive multiple sclerosis patients.
[Neuropathology of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy].
Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.
Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
Reimbursement and market access of multiple sclerosis products in the United States.
The best clinical paper on multiple sclerosis in 2012: Commentary.
[Neuroimmunology: theoretical and clinical aspects].
Factors influencing the desire to provide MS patient care in clinical practice among physiatrists.
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.

Pages